ESTI-STS: The Effects of Standardized vs Individualized Seat Height on 1-minute Sit-to-stand Performance

Sponsor

University of Zurich (Other)

Overall Status

Recruiting

CT.gov ID

NCT04772417

Collaborator

(none)

Enrollment

Location

Anticipated Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The 1-minute sit-to-stand test (1MSTS) is a widely used functional capacity test and has promising predictive potential. Current standards of practice suggest the use of a chair with a standardized height. However, this practice makes the test more demanding for taller individuals than for shorter individuals. This implies over- or underestimation of functional capacity depending on body morphology.

Therefore, the aim of this study is to investigate the influence of knee joint angle, femur length and bodyweight on the 1MSTS performance in healthy subjects with different morphology.

Condition or Disease	Intervention/Treatment	Phase
Healthy Individuals	Diagnostic Test: Standardized 1-minute sit-to-stand test Diagnostic Test: Individualized 1-minute sit-to-stand test

Detailed Description

This is a randomized cross-over trial with the participants performing both procedures twice in one visit. Sufficient breaks in between the tests is granted.

Study Design

Study Type:

Observational

Anticipated Enrollment :

30 participants

Observational Model:

Other

Time Perspective:

Cross-Sectional

Official Title:

The Effects of Standardized vs Individualized Seat Height on 1-minute Sit-to-stand Performance

Anticipated Study Start Date :

Apr 1, 2021

Anticipated Primary Completion Date :

Jul 1, 2021

Anticipated Study Completion Date :

Jul 1, 2021

Outcome Measures

Primary Outcome Measures

Repetitions in the 1-minute sit-to-stand test [Day 1]
Comparison between the procedures

Secondary Outcome Measures

Predictors towards performance in the 1-minute sit-to-stand test [Day 1]
Comparison between the procedures

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Informed consent as documented by signature
Age 18 and older
Healthy
Ability to conduct a 1-minute sit-to-stand-test
Ability to follow study procedures and instructions in German

Exclusion Criteria:

Known cardiopulmonary or metabolic diseases (e.g., heart disease, diabetes mellitus etc.)
Smoking (ex-smoker allowed; if they stopped smoking at least one year before the study inclusion)
Physical or intellectual impairment precluding informed consent or protocol adherence
Respiratory infection in the last two weeks
Pain during sit-to-stand movement

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University Hospital Zurich	Zurich		Switzerland	8091

Sponsors and Collaborators

University of Zurich

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

University of Zurich

ClinicalTrials.gov Identifier:

NCT04772417

Other Study ID Numbers:

2020-02945

First Posted:

Feb 26, 2021

Last Update Posted:

Mar 11, 2021

Last Verified:

Mar 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Mar 11, 2021